Agalawatte Plantation Limited operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Agalawatte Plantation Limited with three other
miscellaneous service companies in Asia:
Medigen Biotechnology Corporation
sales of 407.31 million Taiwanese Dollars [US$13.24 million]
of which 83%
was Drug Discovery),
Sofiva Genomics Co Ltd
(459.40 million Taiwanese Dollars [US$14.93 million]
of which 96%
was Testing service-Taiwan), and
Genomics Biosci &Tech Co Ltd
based in Taiwan
(438.69 million Taiwanese Dollars [US$14.26 million]
Agalawatte Plantation Limited reported sales of 2.65 billion Sri Lanka Rupees (US$14.70 million)
December of 2018.
increase of 31.6%
versus 2017, when the company's sales were 2.02 billion Sri Lanka Rupees.